To the Editors:

I read with great interest the article in your journal by Lucaccioni et al. entitled "Severe metabolic alkalosis due to diuretic treatment in a patient with distal renal tubular acidosis: a rare association" ([@ref1]). The authors reported a neonate with distal renal tubular acidosis (dRTA) who presented with hyperchloremic metabolic alkalosis after hydrochlorothiazide (HCT) treatment.

Although extremely rare, 2 infants with dRTA who developed metabolic alkalosis have previously been reported ([@ref2], [@ref3]). McSherry reported a 4-month-old infant with dRTA who developed hypochloremic metabolic alkalosis and severe hypokalemia following HCT treatment ([@ref2]). Hymes et al reported a 7-month-old infant with dRTA who presented with hypochloremic metabolic alkalosis and hypokalemia after a 4-day history of vomiting, without HCT treatment ([@ref3]). The authors of both reports suggested that severe metabolic alkalosis in their patients appeared related to hypokalemia and extracellular volume depletion.

Metabolic alkalosis can be caused by potassium depletion and/or chloride depletion due to gastric fluid loss or the chloruretic effect of a diuretic ([@ref4]). The patient in the report by Lucaccioni et al. presented with hypokalemia, hypochloremia, and dehydration following HCT treatment and vomiting, leading to severe metabolic alkalosis ([@ref1]). Patients with dRTA who have hypokalemia and are treated by a thiazide diuretic and/or have persistent vomiting episodes should be need to be caution for the onset of metabolic alkalosis.
